Press Releases Bavarian Nordic A/S OTC Markets

Equities

BVNR.Y

US0717711099

Market Closed - OTC Markets Other stock markets 03:59:41 2024-05-06 pm EDT			5-day change	1st Jan Change
7.68 ^USD	+3.09%		+5.93%	-12.18%

Apr. 30	Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine	MT
Apr. 29	Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve	Apr. 29	GL
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate	Apr. 29	GL
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	Apr. 23	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	Apr. 22	GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S	Apr. 16	GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine	Apr. 04	AQ
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	Apr. 02	GL
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	Apr. 02	AQ
Bavarian Nordic A/S : Notice Convening Annual General Meeting	Mar. 21	PU
Bavarian Nordic A/S – Notice Convening Annual General Meeting	Mar. 21	GL
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland	Mar. 13	GL
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH	Mar. 13	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	Mar. 12	GL
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH	Mar. 07	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	Mar. 06	GL
Bavarian Nordic Publishes Annual Report 2023	Mar. 06	GL
BAVARIAN NORDIC'S CHIKUNGUNYA VACCINE CANDIDATE GRANTED ACCELERATED ASSESSMENT BY EUROPEAN MEDICINES AGENCY	Feb. 26	AQ
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency	Feb. 23	GL
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency	Feb. 23	AQ
ExpreS2ion's Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic's Clinical Phase III Study for the COVID-19 Vaccine	Feb. 21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bavarian Nordic A/S OTC Markets

Equities

BVNR.Y

US0717711099

Press Releases

Filters